Darovasertib (LXS-196, NVP-LXS196, IDE196)

Darovasertib (CAS No.: 1874276-76-2), is a potent, selective and orally active protein kinase C (PKC) inhibitor, with IC₅₀ values of 1.9 nM, 0.4 nM and 3.1 μM for PKCα, PKCθ and GSK3β, respectively. Darovasertib has the potential for uveal melanoma research. >98% Purity.

Synonyms: LXS-196, IDE-196, LXS196, IDE196, protein kinase C inhibitor, PKC inhibitor

For Research Use Only.